Nurix Therapeutics Inc (NRIX)
15.40
-0.50
(-3.14%)
USD |
NASDAQ |
May 16, 16:00
15.38
-0.02
(-0.10%)
After-Hours: 20:00
Nurix Therapeutics Net Income (Quarterly): -41.52M for Feb. 29, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | -41.52M |
| November 30, 2023 | -41.96M |
| August 31, 2023 | -36.98M |
| May 31, 2023 | -24.28M |
| February 28, 2023 | -40.73M |
| November 30, 2022 | -46.72M |
| August 31, 2022 | -45.71M |
| May 31, 2022 | -45.40M |
| February 28, 2022 | -42.53M |
| November 30, 2021 | -37.70M |
| Date | Value |
|---|---|
| August 31, 2021 | -28.84M |
| May 31, 2021 | -26.38M |
| February 28, 2021 | -24.28M |
| November 30, 2020 | -19.91M |
| August 31, 2020 | -18.52M |
| May 31, 2020 | 7.58M |
| February 29, 2020 | -12.39M |
| November 30, 2019 | -13.52M |
| August 31, 2019 | -2.427M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-46.72M
Minimum
Nov 2022
7.58M
Maximum
May 2020
-28.54M
Average
-28.84M
Median
Aug 2021
Net Income (Quarterly) Benchmarks
| Gilead Sciences Inc | -4.17B |
| ALX Oncology Holdings Inc | -35.58M |
| Vanda Pharmaceuticals Inc | -4.146M |
| GlycoMimetics Inc | -10.74M |
| Immunic Inc | -29.58M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 16.58M |
| Total Expenses (Quarterly) | 61.80M |
| EPS Diluted (Quarterly) | -0.76 |
| Enterprise Value | 696.45M |
| Profit Margin (Quarterly) | -250.3% |
| Earnings Yield | -17.27% |
| Normalized Earnings Yield | -17.27 |